Table 1.
Country | Estimated number of laboratory-confirmed MDR-TB patients in country in 2015* | Laboratory-confirmed MDR-TB patients in country in 2015* n |
MDR-TB patients initiated on treatment in 2015 n |
MDR-TB patients started on BDQ in 2015 n |
Estimated proportion of treated patients started on BDQ % |
---|---|---|---|---|---|
Belarus | 1710 | 1282 | 1949 | 138 | 7.1 |
France | 56 | 111 | 98 | 45 | 45.9 |
Georgia | 640 | 441 | 466 | 128 | 27.5 |
South Africa | 6200 | 18 734 | 12 516 | 1085 | 8.6 |
Swaziland | 460 | 358 | 483 | 30 | 6.2 |
Estimates are based on WHO modeling and include very wide confidence intervals; there may thus be more individuals diagnosed with MDR-TB than the estimates. Of note, there may in some countries be more persons started on MDR-TB treatment than those with confirmed MDR-TB from that year because persons with extra-pulmonary disease, children, close contacts, and others may be started on treatment empirically even in the absence of culture confirmation.
MDR-TB = multidrug-resistant tuberculosis; BDQ = bedaquiline; WHO = World Health Organization.